Effective dose range of candesartan cilexetil for systemic hypertension. Candesartan Cilexetil Study Investigators

Am J Cardiol. 1999 Jan 15;83(2):272-5, A6. doi: 10.1016/s0002-9149(98)00837-6.

Abstract

The results of this randomized, double-blind, placebo-controlled, forced-dose titration study in a diverse population of hypertensive patients in the US indicate that candesartan cilexetil has clinically meaningful dose-related blood pressure-lowering effects and that maximum blood pressure reduction is achieved with doses of 16 and 32 mg given once daily. This study confirms that candesartan cilexetil is a highly effective antihypertensive agent with an excellent tolerability and safety profile, without dose-related adverse effects.

Publication types

  • Clinical Trial
  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antihypertensive Agents / administration & dosage*
  • Benzimidazoles / administration & dosage*
  • Biphenyl Compounds / administration & dosage*
  • Blood Pressure / drug effects
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Female
  • Humans
  • Hypertension / drug therapy*
  • Male
  • Middle Aged
  • Posture
  • Prodrugs / administration & dosage
  • Tetrazoles*

Substances

  • Antihypertensive Agents
  • Benzimidazoles
  • Biphenyl Compounds
  • Prodrugs
  • Tetrazoles
  • candesartan cilexetil